Text Size

Quantification of Upper Extremity Hypertonia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Terence Sanger, University of Southern California
ClinicalTrials.gov Identifier:
NCT00285870
First received: January 31, 2006
Last updated: March 11, 2013
Last verified: March 2013
History of Changes
  Purpose

Dr. Sanger and the research team want to learn about upper extremity hypertonia (stiffness) in children and young adults with cerebral palsy. Specifically, they want to learn about ways to measure the stiffness in the joints of hypertonic arms. The information the research team will collect includes any physical exams or computer generated data about your arm movements.


Condition
Dystonia
Muscle Hypertonia

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Quantification of Upper Extremity Hypertonia

Resource links provided by NLM:

MedlinePlus related topics: Dystonia
U.S. FDA Resources

Further study details as provided by University of Southern California:

Primary Outcome Measures:
  • Observation [ Time Frame: 1 hour ] [ Designated as safety issue: No ]

Enrollment: 60
Study Start Date: January 2006
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   4 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Children with cerebral palsy and/or dystonia.

Criteria

Inclusion Criteria:Dystonia in at least one arm Age 4 to no upper limit

Exclusion Criteria:increased risk of participation botulinum toxin within 6 months

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00285870

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
University of Southern California
Investigators
Principal Investigator: Terence D. Sanger Stanford University
  More Information

No publications provided

Responsible Party: Terence Sanger, Associate Professor, University of Southern California
ClinicalTrials.gov Identifier: NCT00285870     History of Changes
Other Study ID Numbers: UPPER EXTREMITY HYPERTONIA
Study First Received: January 31, 2006
Last Updated: March 11, 2013
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Dystonia
Dystonic Disorders
Muscle Hypertonia
Dyskinesias
Neurologic Manifestations
 Nervous System Diseases
Signs and Symptoms
Movement Disorders
Central Nervous System Diseases
Neuromuscular Manifestations

ClinicalTrials.gov processed this record on May 19, 2013